Loading...

Dorie Apollonio, PhD

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address3333 California Street
San Francisco CA 94118
Phone415-502-1942
ORCID ORCID Icon0000-0003-4694-0826 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoAmerican Legacy Foundation Fellow
    University of California, BerkeleyPhD
    Harvard University, Cambridge, MAMPP
    Macalester College, St. Paul, MNBA

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Linking local variation in marijuana and opioid policies to health outcomes
    NIH R21DA046051Feb 1, 2019 - Jan 31, 2021
    Role: Principal Investigator
    Effects of California’s 2016 tobacco policies on initiation, use, & quitting
    California Tobacco-Related Disease Research Program 26IR-0014Jul 1, 2017 - Jun 30, 2019
    Role: PI
    Measuring combined tobacco, e-cigarette, and marijuana use in California
    California Tobacco-Related Disease Research Program 25IR-0025Nov 1, 2016 - Jun 30, 2019
    Role: Co-PI
    San Francisco Cancer Initiative (SF-CAN)
    UCSF Helen Diller Family Comprehensive Cancer Center Jul 1, 2016 - Jun 30, 2019
    Role: Co-investigator
    Uses of evidence in health policy
    UCSF Research Allocation Program Jul 1, 2015 - Dec 1, 2016
    Role: PI
    State and local policies addressing the use and sale of non-cigarette tobacco products
    NIH/NCI U01 CA 154240Oct 1, 2014 - Sep 3, 2015
    Role: Co-investigator
    Partnership to Advance Breast Cancer Research
    California Breast Cancer Research Program Jan 1, 2014 - Dec 31, 2014
    Role: Co-investigator on subaward
    Translating Research into Systemic Interventions for Tobacco Cessation
    NIH K07CA140236Sep 13, 2011 - Aug 31, 2016
    Role: Principal Investigator
    Creating systemic tobacco control interventions in marginalized populations
    American Cancer Society A114962Jul 1, 2010 - Dec 31, 2011
    Role: PI
    Role Description: Relinquished in Year 2 due to receipt of competing award

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents. Nicotine Tob Res. 2020 May 26; 22(6):967-974. Apollonio DE, Glantz SA. PMID: 31058282.
      View in: PubMed   Mentions:    Fields:    
    2. Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents. Tob Control. 2020 Jan 22. Apollonio DE, Glantz S. PMID: 31969381.
      View in: PubMed   Mentions:    Fields:    
    3. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database of Systematic Reviews. 2019; 8. View Publication.
    4. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database of Systematic Reviews. 2019 Sep 2; (9). Maya Vijayaraghavan, Holly Elser, Dorie Apollonio. .
      View in: Publisher Site   Mentions:
    5. In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign. BMC Public Health. 2019 Aug 22; 19(1):1150. Kearns CE, Glantz SA, Apollonio DE. PMID: 31438900.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. A review of tobacco policies on University of California campuses. Californian Journal of Health Promotion. 2019; 1(17):24-30. View Publication.
    7. Placement and sales of tobacco products and nicotine replacement therapy in tobacco-free and tobacco-selling pharmacies in Northern California: an observational study. BMJ Open. 2019 06 14; 9(6):e025603. Pimentel L, Apollonio DE. PMID: 31203236.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Review of Tobacco Policies on University of California Campuses. Californian Journal of Health Promotion. 2019 Jun 1; 17(1):24-30. Jocelyn Huey, Dorie E. Apollonio. .
      View in: Publisher Site   Mentions:
    9. Typologies of Party Finance Systems: A Comparative Study of How Countries Regulate Party Finance and Their Institutional Foundations. Election Law Journal Rules Politics and Policy. 2019 Apr 30; 18(3):243-261. David L. Wiltse, Raymond J. La Raja, Dorie E. Apollonio. .
      View in: Publisher Site   Mentions:
    10. Prevalence and Correlates of Simultaneous and Separate 30-Day Use of Tobacco and Cannabis: Results from the California Adult Tobacco Survey. Subst Use Misuse. 2019; 54(10):1627-1632. Apollonio DE, Spetz J, Schmidt L, Jacobs L, Kaur M, Ramo D. PMID: 30973038.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Engaging Adults Experiencing Homelessness in Smoking Cessation Through Large-Scale Community Service Events. Health Promot Pract. 2019 05; 20(3):325-327. Vijayaraghavan M, Apollonio DE. PMID: 30845844.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Pharmacy students can improve access to quality medicines information by editing Wikipedia articles. BMC Med Educ. 2018 Nov 20; 18(1):265. Apollonio DE, Broyde K, Azzam A, De Guia M, Heilman J, Brock T. PMID: 30454046.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC Public Health. 2018 Sep 17; 18(1):1129. Huey J, Apollonio DE. PMID: 30223799.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2019 05; 28(3):274-281. Apollonio DE, Glantz SA. PMID: 29954860.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. The sugar industry's influence on policy. Science. 2018 05 04; 360(6388):501. Kearns C, Schmidt L, Apollonio D, Glantz S. PMID: 29724946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. 2018. Tsoh J, Apollonio DE, Hall S, Vijayaraghvan M, Ramo DE, Ling P, Lempert LL, Glantz SA. FDA’s Nicotine Steering Committee should develop policies, regulations, and procedures that promote cessation and increase the use of proven therapies. US FDA Public Comment, Docket FDA-2018-N-0128.
    17. 2018. Apollonio DE, Glantz SA, Hall S, Lempert LL, St.Helen G, Tsoh J. The FDA should not adopt the nicotine “harm reduction” paradigm because doing so is likely to increase the amount of smoking-caused disease and death. US FDA Public Comment, Docket FDA-2017-N-6529.
    18. Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol. 2017 Nov; 15(11):e2003460. Kearns CE, Apollonio D, Glantz SA. PMID: 29161267.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    19. Sustainable Pharmacy: Piloting a Session on Pharmaceuticals, Climate Change, and Sustainability within a U.S. Pharmacy Curriculum. INNOVATIONS in pharmacy. 2017 Oct 12; 8(4):3. Katherine Gruenberg, Dorie Apollonio, Conan MacDougall, Tina Brock. .
      View in: Publisher Site   Mentions:
    20. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health. 2017 10; 107(10):1636-1642. Apollonio D, Glantz SA. PMID: 28817320.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs. Health Promot Pract. 2017 07; 18(4):571-580. Sung H, Apollonio DE. PMID: 28438037.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738. Apollonio DE, Bero LA. PMID: 28219958.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274. Apollonio D, Philipps R, Bero L. PMID: 27878808.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822. Apollonio DE, Wolfe N, Bero LA. PMID: 27539238.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    25. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141. Apollonio DE, Bero LA. PMID: 27721899.
      View in: PubMed   Mentions:
    26. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 07; 106(7):1200-7. Apollonio DE, Glantz SA. PMID: 27196658.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis. 2015; 13:33. Krauth D, Apollonio DE. PMID: 26500471.
      View in: PubMed   Mentions:
    28. Accuracy of popular media reporting on tobacco cessation therapy in substance abuse and mental health populations. BMJ Open. 2015 Mar 26; 5(3):e007169. Krauth D, Apollonio D. PMID: 25814498.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Karma police: Prosecutorial strategies in obscenity cases and the broader cultural war. Syracuse Law and Civic Engagement Forum. 2015; (2):1-24. Lochner T, Apollonio DE..
    30. Tobacco industry efforts to influence policy: when interest groups face opposition. Interest Group Politics. 2015. Apollonio DE..
    31. Political advocacy in pharmacy: challenges and opportunities. Integr Pharm Res Pract. 2014; 3:89-95. Apollonio DE. PMID: 26301185.
      View in: PubMed   Mentions:
    32. Karma Police: Prosecutorial Strategies in Obscenity Cases and the Broader Culture War. Syracuse Law Civ Engagem. 2014; 2. Lochner T, Apollonio D. PMID: 28090607.
      View in: PubMed   Mentions:
    33. Term limits and the tobacco industry. Soc Sci Med. 2014 Mar; 104:1-5. Apollonio DE, Glantz SA, Bero LA. PMID: 24581055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Immigration and Prosecutorial Discretion. Calif J Politics Policy. 2013; 5(2):232-251. Apollonio D, Lochner T, Heddens M. PMID: 26146530.
      View in: PubMed   Mentions:
    35. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr. 2012 Dec 01; 12:1-10. Apollonio D, Philipps R, Bero L. PMID: 23833567.
      View in: PubMed   Mentions:
    36. The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation. Am J Public Health. 2010 Jul; 100(7):1188-201. Apollonio DE, Malone RE. PMID: 20466965.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    37. Interest Groups. Developments in American Politics 6. 2010 Jan 1; 67-83. Dorie E. Apollonio. .
      View in: Publisher Site   Mentions:
    38. Evidence and argument in policymaking: development of workplace smoking legislation. BMC Public Health. 2009 Jun 17; 9:189. Apollonio DE, Bero LA. PMID: 19534777.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    39. Turning negative into positive: public health mass media campaigns and negative advertising. Health Educ Res. 2009 Jun; 24(3):483-95. Apollonio DE, Malone RE. PMID: 18948569.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    40. Wheat from chaff: Third-party monitoring and FEC enforcement actions. Regulation & Governance. 2008 Jun 1; 2(2):216-233. Todd Lochner, Dorie Apollonio, Rhett Tatum. .
      View in: Publisher Site   Mentions:
    41. Access and lobbying: Looking beyond the corruption paradigm. Hastings Constitutional Law Quarterly. 2008; 1(36):13-50. Apollonio DE, Cain BE, Drutman L.
    42. Interest Groups, Lobbying, and Deception: The Tobacco Industry and Airline Smoking. Political Science Quarterly. 2007 Dec 1; 122(4):635-656. PEGGY LOPIPERO, DORIE E. APOLLONIO, LISA A. BERO. .
      View in: Publisher Site   Mentions:
    43. Participation and argument in legislative debate on statewide smoking restrictions. Health Res Policy Syst. 2007 Oct 22; 5:12. Apollonio DE, Lopipero P, Bero LA. PMID: 17953767.
      View in: PubMed   Mentions: 5     Fields:    
    44. The creation of industry front groups: the tobacco industry and "get government off our back". Am J Public Health. 2007 Mar; 97(3):419-27. Apollonio DE, Bero LA. PMID: 17267719.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    45. Industry front groups: A tobacco case study. Journal of consumer protection and food safety. 2007; 3(2):341-348. Apollonio DE, Bero LA.
    46. Term Limits, Campaign Contributions, and the Distribution of Power in State Legislatures. Legislative Studies Quarterly. 2006 May 1; 31(2):259-281. D.E. APOLLONIO, RAYMOND J. RAJA. .
      View in: Publisher Site   Mentions:
    47. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005 Dec; 14(6):409-15. Apollonio DE, Malone RE. PMID: 16319365.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    48. Interest Group Advocacy and the Power of "Magic Words". Election Law Journal Rules Politics and Policy. 2005 Sep 1; 4(3):178-190. Dorie E. Apollonio, Margaret A. Carne. .
      View in: Publisher Site   Mentions:
    49. Predictors of interest group lobbying decisions. The forum. 2005; 3(3):1-20. Apollonio DE..
    50. The season of our discontent: Voters’ views on California elections. Public Policy Institute of California. 2004. Baldassare MA, Cain BE, Apollonio DE, Cohen JM.
    51. Who gave soft money? The effect of interest group resources on political contributions. The journal of politics. 2004; 4(66):1159-1179. Apollonio DE, La Raja RJ.
    52. Roper Social and Political Trends Data (1973-1994). 2000. Brady HE, Putnam RD, Campbell AL, Elms LE, Yonish S, Apollonio DE..
    53. Term limits affect legislators’ fund raising prowess. Public affairs report. 1999; 5(40). La Raja RJ, Apollonio DE..
    54. Trends in American political participation, 1973-1994. 1998. Brady HE, Apollonio DE, Elms LE.
    Dorie's Networks
    Concepts (110)
    Derived automatically from this person's publications.
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _